Skip to main content


Fig. 4 | Respiratory Research

Fig. 4

From: Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis

Fig. 4

Mean change from baseline in patients with early (CID+) or late (CID-) CID events. Mean change from baseline over the full study duration in A) FEV1, B) SGRQ, C) reliever use and D) symptoms in patients with early (CID+) or late (CID-) CID events. Total symptoms (sum of Breathlessness, Cough, and Sputum Scale [BCSS©] scores) were based on weekly means of daily observations. BUD, budesonide; CID, Clinically Important Deterioration; FEV1, forced expiratory volume in 1 second; FORM, formoterol; SGRQ, St George’s Respiratory Questionnaire

Back to article page